Construction method of multi-organ controlled hemorrhage model

By constructing a multi-organ controlled bleeding model using femoral artery puncture and catheterization and DSA fluoroscopy, this method overcomes the shortcomings of existing multi-organ bleeding simulation techniques, achieves precise control of bleeding volume and high model repeatability, and is suitable for medical teaching and scientific research experiments.

CN118986570APending Publication Date: 2024-11-22THE FIFTH MEDICAL CENT OF CHINESE PLA GENERAL HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411085531.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-08
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing technologies cannot effectively simulate multi-organ bleeding, have low experimental repeatability, uncontrollable bleeding rate and volume, and poor reliability of animal models caused by surgical trauma.

Method used

A multi-organ controlled bleeding model was constructed using femoral artery puncture and catheterization combined with DSA fluoroscopy. The amount of bleeding was precisely controlled by a micro-sheath three-way valve, and medical-grade materials were used to ensure biocompatibility and safety.

Benefits of technology

It achieves realistic simulation of multi-organ bleeding model, with precise control of bleeding volume, minimal trauma, low technical difficulty, small inter-individual differences, and high model repeatability, making it suitable for medical teaching and scientific research experiments.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004985080150000011
    Figure HDA0004985080150000011
  • Figure HDA0004985080150000012
    Figure HDA0004985080150000012
Patent Text Reader

Abstract

The invention relates to the technical field of animal model construction, and particularly discloses a construction method of a multi-organ controlled hemorrhage model. The construction method of the multi-organ controlled hemorrhage model comprises the following steps of femoral artery puncture catheterization, hepatic artery hemorrhage model construction, renal artery hemorrhage model construction, superior mesenteric artery hemorrhage model construction and iliac artery hemorrhage model construction. The method comprises the following steps of: firstly, anesthetizing a model animal, selecting a part which is 1.5-3.0 cm away from the inner lower part of the midpoint of the inguinal ligament on one side and is obvious in femoral artery pulsation as a puncture point, marking the puncture point, puncturing a blood vessel by using an inclined plane of a puncture needle upwards at a puncture angle of 30-45 degrees, spraying pulsatile blood flow out from the tail end of the puncture needle, slowly feeding a guide wire, withdrawing the puncture needle, and performing puncture and catheterization on the puncture needle. The artery sheath is placed into the femoral artery along the guide wire. According to the construction method, the multi-organ bleeding condition can be well simulated, accurate control over the multi-organ bleeding amount is achieved, the repeatability of the multi-organ controlled bleeding model is high, and the use requirements of scientific research experiments, medical teaching and the like can be met.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of animal model construction, and specifically to a method for constructing a multi-organ controlled bleeding model. Background Art

[0002] Among the large number of traumatic casualties caused by major traffic accidents, various natural disasters and other emergencies, local or systemic uncontrollable massive bleeding is the main cause of death. Bleeding caused by trauma usually includes tissue damage, vascular rupture, limb separation, and solid organ rupture. Therefore, constructing an animal model that simulates the occurrence of bleeding in casualties is of great significance for the emergency treatment of bleeding in casualties.

[0003] At present, animal bleeding models are usually constructed using methods such as open surgical trauma and drug induction. Although these methods have certain effects in simulating single-organ bleeding, they have limitations in simulating multi-organ bleeding and cannot truly reflect the mutual influence and complex pathological changes among multiple organs. Secondly, in the method of constructing a bleeding model through surgical trauma, due to the subjectivity of surgical instruments and operators, it usually causes problems such as different wound sizes of experimental animals, inability to accurately control the bleeding speed, non-quantifiable bleeding volume, and low model repeatability, resulting in poor reliability of the animal bleeding model in subsequent applications.

[0004] Therefore, constructing a multi-organ bleeding model is of great significance for studying complex pathological processes such as hemorrhagic shock and its complications. Summary of the invention

[0005] In order to solve the problems that the existing traumatic aortic bleeding model cannot effectively simulate multi-organ bleeding, has low experimental repeatability, cannot accurately control the bleeding rate, and the bleeding volume cannot be quantified, the present application provides a method for constructing a multi-organ controlled bleeding model.

[0006] In the first aspect, the present application provides a method for constructing a multi-organ controlled bleeding model, which adopts the following technical solution: A method for constructing a multi-organ controlled bleeding model, comprising the following steps: puncturing and catheterizing the femoral artery, constructing a hepatic artery bleeding model, constructing a renal artery bleeding model, constructing a superior mesenteric artery bleeding model, and constructing an iliac artery bleeding model; The specific steps of the femoral artery puncture and catheterization are as follows: first, anesthetize the model animal, select the puncture point 1.5-3.0 cm below the midpoint of the inguinal ligament on one side and the place where the femoral artery pulsation is obvious as the puncture point and mark it, insert the puncture needle with the bevel upward at a puncture angle of 30-45° to puncture the blood vessel, and see pulsating blood flow spurting out from the tail end of the puncture needle, then slowly insert the guide wire, withdraw the puncture needle, and place the arterial sheath into the femoral artery along the guide wire.

[0007] Optionally, the specific steps of constructing the hepatic artery bleeding model are: inserting the angiography catheter into the arterial sheath, sending it to the secondary branch of the hepatic artery for angiography, confirming the site to be punctured, sending the tail end of the hardened guide wire through the angiography catheter to the site to be punctured, and forcefully piercing the blood vessel wall and liver capsule until the tail end of the guide wire protrudes from the surface of the liver, locating the position of the tail end of the guide wire under DSA fluoroscopy, incising the position along the skin, finding the tail end of the guide wire, and pulling it out with curved forceps; using a 4F or 5F micro sheath to pierce the skin along the tail end of the guide wire and insert it into the hepatic artery, withdrawing the hardened guide wire, and opening the three-way valve of the micro sheath until arterial blood gushes out of the sheath.

[0008] Optionally, the specific steps of constructing the renal artery bleeding model are: sending the angiography catheter to the renal artery for angiography, confirming the puncture site, sending the tail end of the hardened guide wire through the angiography catheter to the puncture site, forcefully puncturing the blood vessel wall until the tail end of the guide wire protrudes from the surface of the kidney, turning the body position, locating the tail end of the guide wire under DSA fluoroscopy, incising the position along the skin, finding the tail end of the guide wire, and pulling it out with curved forceps; using a 4F or 5F micro sheath to pierce the skin from the tail end of the guide wire and insert it into the renal artery, withdrawing the hardened guide wire, and opening the three-way valve of the micro sheath until arterial blood gushes out of the sheath.

[0009] Optionally, the specific steps of constructing the superior mesenteric artery bleeding model are: inserting the angiography catheter into the arterial sheath, sending it to the superior mesenteric artery for angiography, confirming the site to be punctured, sending the tail end of the hardened guide wire through the angiography catheter to the site to be punctured, and forcefully puncturing the blood vessel wall until the tail end of the guide wire protrudes from the surface of the intestinal tube, locating the position of the tail end of the guide wire under DSA fluoroscopy, incising the position along the skin, finding the tail end of the guide wire, and pulling it out with curved forceps; using a 4F or 5F micro sheath to pierce the skin from the tail end of the guide wire and insert it into the superior mesenteric artery, withdrawing the hardened guide wire, and opening the three-way valve of the micro sheath until arterial blood gushes out of the sheath.

[0010] Optionally, the specific steps for constructing the iliac artery bleeding model are: after successful puncture of the femoral artery, a 4F or 5F micro-perforator sheath is inserted into the iliac artery along the femoral artery puncture point, iliac artery angiography is performed, and confirmation is made that the tip of the sheath is located in the iliac artery. The three-way valve of the micro-perforator sheath is opened until arterial blood flows out of the sheath.

[0011] In the method for constructing a multi-organ controlled bleeding model of the present application, the arterial sheath, angiography catheter, hardened guidewire and micro-sheath are all made of medical-grade materials, which effectively ensures biocompatibility and operational safety.

[0012] Optionally, the model animal is selected from pigs and dogs.

[0013] Optionally, the model animal is anesthetized with a mixture of Sumianxin and Shutai.

[0014] In a specific embodiment, the SuMianXin and ShuTai are diluted 10 times each, and then mixed in a volume ratio of 1:1 to prepare a mixed solution.

[0015] Optionally, the amount of bleeding in multiple organs can be precisely controlled by controlling the three-way valve of the microsheath.

[0016] In a second aspect, the present application provides a multi-organ controlled bleeding model, which is obtained using the aforementioned method for constructing a multi-organ controlled bleeding model.

[0017] Thirdly, the multi-organ controlled bleeding model provided in this application is used in medical teaching, scientific research experiments, hemostatic material evaluation, and hemostatic technology evaluation.

[0018] In summary, this application has the following beneficial effects: 1. The present application provides a method for constructing a multi-organ controlled bleeding model. The method uses femoral artery puncture catheterization technology + DSA fluoroscopy technology to truly simulate the bleeding of multiple organs and pelvic arteries, and achieves precise control of bleeding volume through a micro-sheath three-way valve.

[0019] 2. The method for constructing a multi-organ controlled bleeding model provided in this application has the advantages of less trauma, low technical difficulty, and small individual differences after modeling. In addition, the obtained multi-organ controlled bleeding model will not have complications and death, and the modeling success rate is high.

[0020] 3. The method for constructing a multi-organ controlled bleeding model provided in this application can obtain a series of completely identical animal multi-organ bleeding models. The above-mentioned animal model can be used in medical teaching, scientific research experiments, hemostatic material evaluation, hemostatic technology evaluation, etc. It has the advantages of good experimental repeatability and good experimental reliability, and is of great significance for studying complex pathological processes such as hemorrhagic shock and its complications. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 This is a photo of renal artery contrast agent extravasation in a multi-organ controlled bleeding model; Figure 2 These are photos of hemostasis after embolization of a multi-organ controlled bleeding model using hemostatic materials. DETAILED DESCRIPTION

[0022] The present application provides a method for constructing a multi-organ controlled bleeding model, comprising the following steps: (1) Femoral artery puncture and catheterization: First, anesthetize the model animal, select the puncture point 1.5-3.0 cm below the midpoint of the inguinal ligament on one side, and mark the place where the femoral artery pulsation is obvious. At a puncture angle of 30-45°, insert the puncture needle with the bevel upward to puncture the blood vessel. When pulsating blood flow is seen spurting out from the tail end of the puncture needle, slowly insert the guide wire, withdraw the puncture needle, and place the arterial sheath into the femoral artery along the guide wire.

[0023] (2) Construction of hepatic artery bleeding model: The angiography catheter was placed into the arterial sheath and sent to the secondary branch of the hepatic artery for angiography. The site to be punctured was confirmed. The tail end of the hardened guide wire was sent to the site to be punctured through the angiography catheter. The vessel wall and liver capsule were punctured with force until the tail end of the guide wire protruded from the liver surface. The tail end of the guide wire was located under DSA fluoroscopy. The position was located by incising along the skin. The tail end of the guide wire was found and pulled out with curved forceps. A 4F or 5F micro-sheath was used to pierce the skin along the tail end of the guide wire and inserted into the hepatic artery. The hardened guide wire was removed and the three-way valve of the micro-sheath was opened until arterial blood gushed out of the sheath.

[0024] (3) Construction of renal artery bleeding model: The angiography catheter was sent to the renal artery for angiography to confirm the puncture site. The tail end of the hardened guide wire was sent to the puncture site through the angiography catheter. The blood vessel wall was punctured forcefully until the tail end of the guide wire protruded from the surface of the kidney. The patient was turned over and the tail end of the guide wire was located under DSA fluoroscopy. The skin was incised to locate the tail end of the guide wire and the guide wire was pulled out with curved forceps. A 4F or 5F micro sheath was used to pierce the skin from the tail end of the guide wire and insert it into the renal artery. The hardened guide wire was removed and the three-way valve of the micro sheath was opened until arterial blood gushed out of the sheath.

[0025] (4) Construction of the superior mesenteric artery bleeding model: The angiography catheter was placed into the arterial sheath and sent to the superior mesenteric artery for angiography. The site to be punctured was confirmed. The tail end of the hardened guide wire was sent to the site to be punctured through the angiography catheter. The blood vessel wall was punctured with force until the tail end of the guide wire protruded from the surface of the intestinal tube. The tail end of the guide wire was located under DSA fluoroscopy. The position was located by incising along the skin. The tail end of the guide wire was found and pulled out with curved forceps. A 4F or 5F micro-sheath was used to pierce the skin from the tail end of the guide wire and insert it into the superior mesenteric artery. The hardened guide wire was withdrawn and the three-way valve of the micro-sheath was opened until arterial blood gushed out of the sheath.

[0026] (5) Construction of iliac artery bleeding model: After successful femoral artery puncture, a 4F or 5F micro-perforator sheath was inserted into the iliac artery along the femoral artery puncture point, and iliac artery angiography was performed to confirm that the tip of the sheath was located in the iliac artery. The three-way valve of the micro-perforator sheath was opened until arterial blood flowed out of the sheath.

[0027] In the present application, the arterial sheath was purchased from Terumo Corporation of Japan; the angiography catheter was purchased from Cordis of the United States; the hardened guidewire was purchased from Terumo Corporation of Japan; the micro-penetrating sheath was purchased from Cook of the United States; the model of the DSA fluoroscopy equipment was NeuAngio30F Flex, purchased from Neusoft Medical Systems Co., Ltd.; the remaining raw materials, reagents, solvents, etc. can be obtained commercially.

[0028] The present application is further described in detail below in conjunction with the embodiments and accompanying drawings.

[0029] Example 1 Example 1 provides a method for constructing a multi-organ controlled bleeding model, comprising the following steps: (1) Femoral artery catheterization: A total of 10 piglets (5 males and 5 females) aged 35 weeks that passed quarantine inspection were selected. They were then anesthetized with a mixture of Suminxin and Shutai, fixed in a prone position, and the hair around the planned surgical area was removed within 5 cm. The piglets were then disinfected with 75% alcohol under sterile conditions. (2) Select a puncture point 1.5-3.0 cm below and inside the midpoint of the inguinal ligament on one side, where the femoral artery pulsation is obvious, and mark it. At a puncture angle of 30-45°, insert the puncture needle with the bevel upward to puncture the blood vessel. When pulsating blood flow is seen spurting out from the tail end of the puncture needle, slowly insert the guide wire, withdraw the puncture needle, and place the arterial sheath into the femoral artery along the guide wire.

[0030] (3) Construction of hepatic artery bleeding model: The angiography catheter was placed into the arterial sheath and sent to the secondary branch of the hepatic artery for angiography. The site to be punctured was confirmed. The tail end of the hardened guide wire was sent to the site to be punctured through the angiography catheter. The blood vessel wall and liver capsule were punctured with force until the tail end of the guide wire protruded from the liver surface. The tail end of the guide wire was located under DSA fluoroscopy. The position was located by incising along the skin. The tail end of the guide wire was found and pulled out with curved forceps. A 4F or 5F micro-sheath was used to pierce the skin along the tail end of the guide wire and inserted into the hepatic artery. The hardened guide wire was removed and the three-way valve of the micro-sheath was opened. Arterial blood was found to be gushing out of the sheath, indicating that the hepatic artery bleeding model was successfully established.

[0031] (4) Construction of renal artery bleeding model: The angiography catheter was sent to the renal artery for angiography to confirm the puncture site. The tail end of the hardened guide wire was sent to the puncture site through the angiography catheter. The blood vessel wall was punctured forcefully until the tail end of the guide wire protruded from the surface of the kidney. The body was turned over and the tail end of the guide wire was located under DSA fluoroscopy. The position was located by incising along the skin. The tail end of the guide wire was found and pulled out with curved forceps. A 4F or 5F micro sheath was used to pierce the skin from the tail end of the guide wire and insert it into the renal artery. The hardened guide wire was removed and the three-way valve of the micro sheath was opened. Arterial blood was found to be gushing out of the sheath, indicating that the renal artery bleeding model was successfully established.

[0032] (5) Construction of the superior mesenteric artery bleeding model: The angiography catheter was placed into the arterial sheath and sent to the superior mesenteric artery for angiography. The site to be punctured was confirmed. The tail end of the hardened guide wire was sent to the site to be punctured through the angiography catheter. The blood vessel wall was punctured with force until the tail end of the guide wire protruded from the surface of the intestinal tube. The tail end of the guide wire was located under DSA fluoroscopy. The position was located by incising along the skin. The tail end of the guide wire was found and pulled out with curved forceps. A 4F or 5F micro-sheath was used to pierce the skin from the tail end of the guide wire and insert it into the superior mesenteric artery. The hardened guide wire was removed and the three-way valve of the micro-sheath was opened. Arterial blood was found to be gushing out of the sheath, indicating that the superior mesenteric artery bleeding model was successfully established.

[0033] (6) Construction of iliac artery bleeding model: After successful femoral artery puncture, a 4F or 5F micro-perforator sheath was inserted into the iliac artery along the femoral artery puncture point, and iliac artery angiography was performed to confirm that the tip of the sheath was located in the iliac artery. The three-way valve of the micro-perforator sheath was opened, and arterial blood was found to flow out of the sheath, indicating that the iliac artery bleeding model was successfully established.

[0034] Test results According to the method of Example 1, 10 piglets were modeled successfully, and there was no infection, no death, no functional behavioral disorder and no complications. By opening the femoral artery three-way, it was found that the renal artery contrast agent was bleeding. The results of the blood gushing photo were as follows Figure 1 shown.

[0035] Example 2 The hemostatic effect of the hemostatic material was evaluated using the multi-organ controlled bleeding model constructed in Example 1, and the specific steps are as follows: Ten minutes after the successful establishment of the multi-organ controlled bleeding model in Example 1, the bleeding site was embolized using a hemostatic material (metal spring coil, model 5 / 2 mm, Cook, USA).

[0036] Test results The results of angiography are as follows Figure 2 As shown by Figure 2 It can be seen that the bleeding of the piglets' organs stopped (the contrast agent overflow phenomenon disappeared), indicating that the hemostasis of the hemostatic material was successful, and after the embolization, none of the 10 piglets had infection, death, cerebral infarction and other complications. Therefore, it is shown that the construction method of the multi-organ controlled bleeding model provided by the application has good repeatability, can be used to evaluate the performance of medical hemostatic materials, and the results are reliable.

[0037] Although the present invention has been described in detail above with general descriptions and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements may be made thereto based on the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention all fall within the scope of protection claimed by the present invention.

Claims

1. A method for constructing a multi-organ controlled bleeding model, characterized in that: The following steps are involved: Femoral artery puncture and catheterization, hepatic artery bleeding model construction, renal artery bleeding model construction, superior mesenteric artery bleeding model construction, iliac artery bleeding model construction; The specific steps of the femoral artery puncture and catheterization are as follows: first, anesthetize the model animal, select the puncture point 1.5-3.0 cm below the midpoint of the inguinal ligament on one side and the place where the femoral artery pulsation is obvious as the puncture point and mark it, insert the puncture needle with the bevel upward at a puncture angle of 30-45° to puncture the blood vessel, and see pulsating blood flow spurting out from the tail end of the puncture needle, then slowly insert the guide wire, withdraw the puncture needle, and place the arterial sheath into the femoral artery along the guide wire.

2. The method for constructing a multi-organ controlled bleeding model according to claim 1, characterized in that: The specific steps of constructing the hepatic artery bleeding model are as follows: inserting an angiography catheter into the arterial sheath and sending it to the secondary branch of the hepatic artery for angiography, confirming the site to be punctured, sending the tail end of the hardened guide wire through the angiography catheter to the site to be punctured, puncturing the blood vessel wall and the liver capsule with force until the tail end of the guide wire protrudes from the surface of the liver, locating the tail end of the guide wire under DSA fluoroscopy, incising the location along the skin, finding the tail end of the guide wire, and pulling it out with curved forceps; using a 4F or 5F micro-sheath to pierce the skin along the tail end of the guide wire and insert it into the hepatic artery, withdrawing the hardened guide wire, and opening the three-way valve of the micro-sheath until arterial blood gushes out of the sheath.

3. The method for constructing a multi-organ controlled bleeding model according to claim 1, characterized in that: The specific steps of constructing the renal artery bleeding model are as follows: delivering the angiography catheter to the renal artery for angiography, confirming the puncture site, delivering the tail end of the hardened guide wire through the angiography catheter to the site to be punctured, puncturing the blood vessel wall with force until the tail end of the guide wire protrudes from the surface of the kidney, turning the body position, locating the tail end of the guide wire under DSA fluoroscopy, incising the location along the skin, finding the tail end of the guide wire, and pulling it out with curved forceps; using a 4F or 5F micro sheath to pierce the skin from the tail end of the guide wire and insert it into the renal artery, withdrawing the hardened guide wire, and opening the three-way valve of the micro sheath until arterial blood gushes out of the sheath.

4. The method for constructing a multi-organ controlled bleeding model according to claim 1, characterized in that: The specific steps of constructing the superior mesenteric artery bleeding model are as follows: inserting an angiography catheter into the arterial sheath and sending it to the superior mesenteric artery for angiography, confirming the site to be punctured, sending the tail end of the hardened guide wire through the angiography catheter to the site to be punctured, puncturing the blood vessel wall with force until the tail end of the guide wire protrudes from the surface of the intestinal tube, locating the tail end of the guide wire under DSA fluoroscopy, incising the location along the skin, finding the tail end of the guide wire, and pulling it out with curved forceps; using a 4F or 5F micro-sheath to penetrate the skin from the tail end of the guide wire and insert it into the superior mesenteric artery, withdrawing the hardened guide wire, and opening the three-way valve of the micro-sheath until arterial blood gushes out of the sheath.

5. The method for constructing a multi-organ controlled bleeding model according to claim 1, characterized in that: The specific steps of constructing the iliac artery bleeding model are as follows: after successful femoral artery puncture, a 4F or 5F micro-perforator sheath is inserted into the iliac artery along the femoral artery puncture point, iliac artery angiography is performed, and confirmation is made that the tip of the sheath is located in the iliac artery. The three-way valve of the micro-perforator sheath is opened until arterial blood flows out of the sheath.

6. The method for constructing a multi-organ controlled bleeding model according to claim 1, characterized in that: The model animal is selected from pigs and dogs.

7. The method for constructing a multi-organ controlled bleeding model according to claim 1, characterized in that: The model animals were anesthetized with a mixture of Sumianxin and Shutai.

8. The method for constructing a multi-organ controlled bleeding model according to claim 1, characterized in that: By controlling the micro-sheath three-way valve, the amount of bleeding in multiple organs can be accurately controlled.

9. A multi-organ controlled bleeding model, characterized in that: The multi-organ controlled bleeding model is obtained by the construction method of any one of claims 1-8.

10. Application of the multi-organ controlled bleeding model as claimed in claim 9 in medical teaching, scientific research experiments, hemostatic material evaluation, and hemostatic technology evaluation.